Cairo Pharmaceuticals
- 283.51 EGP
- 18.27
- 6.89%
Cairo Pharmaceuticals Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 283.51 |
| Prev. Close | 265.240 |
| Day Range | 266.00 - 315.00 |
| 52WK range | |
| Turnover (M EGP) | 14.94 |
| Volume (M) | 0.05 |
| Number of Trades | 801 |
| Market Cap (M EGP) | 4,234.04 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 283.51 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Kahira Pharmaceuticals' net profits up 22.5% in H1-21/22
Cairo – Mubasher: Kahira Pharmaceuticals posted a 22.47% year-on-year (YoY) increase in profits after tax during the first half (H1) of fiscal year...
Kahira Pharmaceuticals sees EGP 9m block trading deal
Cairo – Mubasher: The Egyptian Exchange (EGX) has announced a block trading deal worth EGP 9.24 million on the shares of Kahira...
Adel Taha Abdel Wahab named Chairman of Kahira Pharmaceuticals
Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the appointment of Adel Taha Abdel Wahab as the company’s Chairman.The...
Kahira Pharmaceuticals posts 12% higher profit in nine...
Cairo – Mubasher: Kahira Pharmaceuticals achieved net profits of EGP 102.9 million in the first nine months of fiscal year (FY) 2020/2021, up by...
Kahira Pharmaceuticals targets EGP 145m profit in FY21/22
Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the planned budget for fiscal year 2021/2022.The company aims to achieve...
